UNSPSC 51284114: Cefteram

This classification denotes a cephalosporin antibiotic with the molecular formula C16H17N9O5S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 74CQ4Q3N63, chemically known as (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-((5-methyl-2h-tetrazol-2-yl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(z)-(o-methyloxime) but generally known as cefteram, which bears US NIH Compound Identifier 6537431.

UNSPSC 51284114 Cefteram is a Commodity code that nominally designates a specific antibiotic product, but recent state and local procurement activity under this code shows little alignment with the code's pharmaceutical scope. The recent opportunities posted against this code span emergency response supplies, pharmacy benefit administration, and generic multi-source pharmaceutical programs — none of which reference cefteram or narrow-spectrum antibiotics specifically. State and local governments are instead using this code designation for broader medical and pharmaceutical procurement that does not match the code's intended product category. The issuing bodies include county health departments, municipal fire departments, state health agencies, and cooperative purchasing alliances across multiple jurisdictions, though the actual goods and services being solicited diverge substantially from what the code's name suggests.

Geographic spread across recent activity includes Florida, Texas, Minnesota, and Oregon, with representation from county-level health systems, city fire departments, multi-state cooperative purchasing vehicles, and state HHS commissions. Representative recent opportunities include Seminole County, Florida's IFB for naloxone and drug deactivation systems (IFB60459723LAS, due July 26, 2023, with 1,900 units of naloxone and 800 Safe Drug Deactivation Systems annually); the City of Tampa's ITB for medical and first aid supplies for the Fire Department Rescue Division (26P00145, due March 13, 2026, estimated contract value $700,000.00, with a certified Small Local Business Enterprise set-aside and 5% bid discount); the Texas Health and Human Services Commission's Request for Information on direct-to-manufacturer prescription programs (HHS0017013, posted April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026, effective July 1, 2026). The code shows limited recent activity directly tied to its nominal pharmaceutical scope and warrants review for coding accuracy before pursuit.